s.aalto
Submits third-party assay reports on material purchased directly. Based in Chennai.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.77%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043551 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | Janoshik | 2026-Q1 | 98.19 | 3.36 | 106.5 | Supplier-supplied | 1 | FAIL |
| AX-2026-043358 | BPC-157 | CPC | CPC-2510-R2456 | Janoshik | 2026-Q1 | 98.63 | 8.50 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041545 | IGF-1 LR3 | QYB | QYB-2512-Y6648 | PeptideMeter | 2026-Q1 | 98.95 | 5.82 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043199 | Semaglutide | GL Biochem | GLBI-2508-D8720 | Janoshik | 2025-Q4 | 98.77 | 4.15 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019042 | BPC-157 | JEEP | JEEP-2506-R3035 | Nordanalyt | 2025-Q3 | 99.31 | 3.26 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020402 | Semax | KP | KP-2502-H4693 | Janoshik | 2025-Q2 | 98.34 | 6.63 | 105.1 | Supplier-supplied | 0 | FAIL |
| AX-2025-020458 | Liraglutide | KP | KP-2502-E5076 | PeptideMeter | 2025-Q1 | 99.54 | 7.11 | — | Supplier-supplied | 0 | PASS |